| scholarly article | Q13442814 |
| P2093 | author name string | Hongbo Wang | |
| Fangxi Zhang | |||
| Jingwei Tian | |||
| Shuren Guo | |||
| Jucan Cheng | |||
| Pinglan Liu | |||
| P2860 | cites work | Triple reuptake inhibitors: the next generation of antidepressants | Q24658248 |
| Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor | Q28209288 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties | Q28248325 | ||
| Pharmacological profile of neuroleptics at human monoamine transporters | Q33857930 | ||
| Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine | Q55982227 | ||
| Major Depressive Disorder | Q56016676 | ||
| The value of the reserpine test in psychopharmacology | Q71237981 | ||
| A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause | Q74741894 | ||
| Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review | Q77720347 | ||
| Adhyperforin: A Homologue of Hyperforin from Hypericum perforatum | Q79567815 | ||
| Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity | Q33939291 | ||
| Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology | Q33940268 | ||
| St John's wort: Prozac from the plant kingdom. | Q33950220 | ||
| Paroxetine: a review. | Q34290151 | ||
| Biologically active and other chemical constituents of the herb of Hypericum perforatum L. | Q34443600 | ||
| Chinese herbal medicine and depression: the research evidence | Q34615943 | ||
| Hyperforin as a possible antidepressant component of hypericum extracts | Q34751517 | ||
| Treatment of mood disorders | Q34982300 | ||
| A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts | Q35614915 | ||
| Chronic mild stress-induced anhedonia: a realistic animal model of depression | Q35655537 | ||
| Potential of St John's Wort for the treatment of depression: the economic perspective. | Q37803219 | ||
| Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats | Q42602477 | ||
| Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress | Q42660322 | ||
| Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort | Q43716451 | ||
| Antidepressant effects of the methanol extract of several Hypericum species from the Canary Islands | Q43823601 | ||
| Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts | Q44233103 | ||
| Effect of agomelatine in the chronic mild stress model of depression in the rat. | Q44374779 | ||
| Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models | Q44456094 | ||
| Antidepressant-like effects of the extract from Cimicifuga foetida L. | Q45752087 | ||
| The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects | Q46369982 | ||
| Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract | Q47763522 | ||
| Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes | Q48357634 | ||
| Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina. | Q48750501 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hypericum perforatum | Q158289 |
| P304 | page(s) | 5632 | |
| P577 | publication date | 2014-07-09 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. | |
| P478 | volume | 4 |
| Q64070868 | An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry |
| Q53682767 | An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms |
| Q36774320 | Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor |
| Q92335902 | Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) and Hypericum Perforatum Modifies In Situ Oral Biofilms |
| Q92136192 | Botanicals as modulators of depression and mechanisms involved |
| Q90412179 | Jieyu Anshen Granule, a Chinese Herbal Formulation, Exerts Effects on Poststroke Depression in Rats |
| Q64262809 | LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain |
| Q92231154 | Opportunities in Novel Psychotropic Drug Design from Natural Compounds |
| Q37636582 | Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. |
| Q55321947 | Silica nanoparticle exposure during the neonatal period impairs hippocampal precursor proliferation and social behavior later in life. |
| Q35932257 | Zuogui Jiangtang Jieyu Formulation Prevents Hyperglycaemia and Depressive-Like Behaviour in Rats by Reducing the Glucocorticoid Level in Plasma and Hippocampus |
Search more.